Thomas Mavrakanas
Assistant Professor, Department of Medicine, Division of Nephrology and Division of Experimental Medicine
My research focuses on the causes of and treatments for cardiovascular disease in patients with chronic kidney disease (CKD) and kidney failure. I have significant expertise in designing pharmacokinetic or observational studies and using large administrative datasets. I was also the first scientist to study the pharmacokinetics of apixaban, a direct oral anticoagulant, at steady state in patients on maintenance dialysis. My work aims to optimize management of patients with chronic kidney and cardiovascular disease in order to prevent occurrence of myocardial infarction, stroke, or admission for heart failure, as well as to slow down CKD progression to kidney failure.
Keywords:
- chronic kidney disease
- kidney failure
- cardiovascular disease
- anticoagulation
- cardiorenal syndromes
- coronary disease
publications list